Target intelligence / Profile preview

Ketosis induction via carbohydrate restriction

01

Overview

"Ketosis induction via carbohydrate restriction" describes the physiological process by which limiting dietary carbohydrates—typically to less than 50 grams per day—leads to depletion of glycogen stores and triggers the liver to produce ketone bodies from fatty acids. This metabolic shift provides an alternative energy source for tissues such as the brain and muscles when glucose availability is low. The state of ketosis can be achieved through various forms of low-carbohydrate diets including the classic ketogenic diet and its variants. While this approach has demonstrated benefits in weight loss and management of certain diseases like type 2 diabetes and epilepsy, it is not itself a discrete molecular target but rather an induced metabolic state resulting from dietary manipulation.[1][2][3][5] Note: This entry does not correspond to any single molecule or receptor; it refers instead to a complex physiological response involving multiple pathways (e.g., insulin signaling reduction, increased lipolysis/ketogenesis). Therefore it should not be treated as a canonical drug target for structured databases.

02

Mechanism of action

Dietary carbohydrate restriction reduces insulin secretion and glycogen stores, leading to increased fatty acid oxidation and hepatic ketone body production

03

Biological functions

Energy metabolismFat oxidationKetone body production
04

Disease associations

ObesityType 2 diabetesEpilepsy (as part of ketogenic diet therapy)Cardiometabolic disease
05

Safety considerations

Initial side effects ("keto flu"): constipation, halitosis, muscle spasms, diarrhea, skin rashPotential for elevated LDL-cholesterol in some individuals on long-term ketogenic diets
06

Biomarkers

Blood beta-hydroxybutyrate (BHB)Acetoacetate levelsUrinary ketones

Beyond the preview

Go deeper on Ketosis induction via carbohydrate restriction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ketosis induction via carbohydrate restriction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call